Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
U.S. Treasury Yields Surge as 30-Year Hits 22-Year High 
Airbus Finds A321neo Fuselage Quality Issue 
US Stock Futures Fall as Treasury Yields Surge Ahead of Trump-Xi Summit 
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 
Trump, Xi Focus on Trade and AI at White House Summit 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
AI is driving down the price of knowledge – universities have to rethink what they offer 
The pandemic is still disrupting young people’s careers 
SMBC Eyes 20% VPBank Stake in Vietnam Expansion 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Erste Group Plans Tender Offer to Boost Poland Bank Stake 
US Backs Musk in Fight Against EU’s €120 Million X Fine 
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Add as a preferred source on Google
Starbucks denies that its decision to stop selling Chicken, Maple Butter, and Egg Sandwich on June 26, a mere five days after it had been announced as a new permanent menu item, was due to FDA recall or salmonella or listeria contamination.
A Starbucks spokesperson said that the Chicken, Maple Butter, and Egg Sandwich was given a voluntary stop sell and discard order by the company because it didn't live up to the company's high standards for quality.
The quality issue that was identified by Starbucks was simply about taste or based on another issue and would not lead to food-borne illness and any reports linking the stop sale to illness are inaccurate.
The spokesperson added that Starbucks is devoted to providing high-quality products, and anytime a concern about a product or its quality is expressed, we always proceed with extreme caution.
